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ABSTRACT
Purpose. To report the clinical and radiographic 
results and complications of the Delta III reverse 
prosthesis.
Methods. 24 women and 2 men aged 62 to 84 (mean, 
75) years underwent total shoulder replacement using 
the Delta III reverse prosthesis. Patient diagnoses were 
massive rotator cuff tear (n=20), disabling sequelae 
of proximal humeral fractures (n=3), and failure of 
an unconstrained arthroplasty (n=3). Clinical and 
functional results were assessed using the Constant 
scale. Active range of motion (ROM) was measured. 
Scapular notching and radiolucent lines around 
the humeral component were evaluated using 
radiographs. Patient satisfaction of the treatment was 
evaluated by a direct interview. 
Results. 23 patients were followed up for 26 to 84 
(mean, 42) months. Two patients had loosening of 
the glenoid component (at 6 months and 5 years) and 
underwent revision surgery. There were no instances 
of infection, instability, or acromial fracture. Only 
active elevation improved significantly after surgery, 
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as did both the absolute and adjusted Constant scores. 
12 patients were completely pain-free, 9 complained 
of slight pain, and one of moderate pain. The severity 
of scapular notching progressed with time. 15 patients 
were satisfied with the treatment, 6 were partially 
satisfied, and 2 were not satisfied.
Conclusion. The Delta III prosthesis restores shoulder 
function but has biomechanical limits. Its use should 
be limited to elderly patients with severe impairment 
of the glenohumeral joint. Scapular notching is a main 
concern for the long-term survival of the implant.
Key words: arthropathy, replacement; prosthesis 
implantation; rotator cuff; shoulder joint
INTRODUCTION
The primary indication for a total shoulder 
replacement using a reverse shoulder prosthesis is the 
‘pseudoparalytic shoulder’, a condition characterised 
by the loss of active arm elevation owing to massive 
and irreparable rotator cuff tears. Glenohumeral 
degeneration or even collapse of the humeral head 
can be attributed to tendon failure and cuff tear 
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arthropathy.1 Other indications include malunions of 
proximal humeral fractures or failed arthroplasties.2 
The semi-constrained design of the reverse shoulder 
prosthesis restores a valid fulcrum for the deltoid, 
enabling overhead elevation of the arm despite the 
absence of the rotator cuff.3
 The Delta III prosthesis (DePuy International, 
Leeds, UK) evolved from the original reverse ball-
and-socket prosthesis,4,5 with 2 new features. First, 
there was a large hemispherical glenoid component 
with no neck, which medialises the centre of shoulder 
rotation and thus reduces stress from the fixed fulcrum 
on the bone-prosthesis interface and increases the 
movement arm of the deltoid. Second, there was a 
155º inclination of the humeral component, which 
lowers the humerus and thus the deltoid tension, so 
as to provide a more stable joint fulcrum. Nonetheless, 
scapular notching is a potential problem, as the 
prosthesis has no neck in the glenoid component, the 
humerus is lowered, and the humeral component has 
a 155º inclination. Bone resorption is mainly caused by 
impingement, followed by polyethylene wear of the 
humeral cup.6 A progressive extension of the notch 
may cause loosening of the glenoid component.7,8 
Other problems of the Delta III prosthesis include 
loss of external rotation, higher risk of dislocation 
and infection, and limited revision options in case of 
failure.2,9–11
 We report the clinical and radiographic results 
and complications of the Delta III reverse prosthesis.
MATERIALS AND METHODS
Between October 2000 and June 2006, 24 women 
and 2 men aged 62 to 84 (mean, 75) years underwent 
total shoulder replacement using a Delta III reverse 
prosthesis. 19 patients had the dominant arm affected; 
12 had undergone previous surgeries. Their diagnoses 
were massive rotator cuff tear with pseudoparalytic 
shoulder (n=5), glenohumeral osteoarthrosis (cuff 
tear arthropathy, n=13), rheumatoid arthritis (n=1), 
shoulder instability (n=1), disabling sequelae of 
proximal humeral fractures (n=3), and failure of an 
unconstrained arthroplasty (n=3). Their comorbidities 
included hypertension (n=8), type-2 diabetes (n=3), 
atrial fibrillation (n=2), benign prostatic hypertrophy 
(n=1), gout (n=1), and major depression (n=1). All 
patients had undergone conservative treatment 
(physical therapy, analgesic and anti-inflammatory 
medications) for at least 3 months. The 20 patients with 
massive rotator cuff tears were classified according to 
the Hamada radiographic grading system12: grades II 
(n=4), III (n=6), IV (n=5), and V (n=5).
 All arthroplasties were performed by the same 
specialist via a deltopectoral approach (n=11) or an 
anterosuperior deltoid-splitting approach (n=15). 
The glenoid base plate (metaglene) was fixed to the 
scapular neck with 4 screws (n=19) or 3 screws (n=7). 
A 36-mm diameter glenosphere was implanted. 
The humeral component was cemented (n=17) or 
uncemented (n=9). The retroversion angle was set 
at 0º (n=7), 10º (n=16) or 20º (n=3). The standard 
lateralised humeral polyethylene cup was used in 25 
patients, whereas a deeper and more constrained cup 
(to prevent instability) was used in one patient with 
a failed arthroplasty. Rehabilitation was approach 
dependent. Active elevation of the shoulder was 
delayed 4 weeks after the anterosuperior approach, 
as the deltoid was partially detached from the 
acromion.
 Clinical and functional results were assessed using 
the Constant scale.13 The adjusted scores were expressed 
as a percentage of normal reference values (matched 
for age and sex).14 Active range of motion (ROM) for 
elevation, external and internal rotation was measured.
 True anteroposterior and axillary radiographs 
were taken at postoperative month 3, 6, and 12, and 
yearly thereafter. Scapular notching was evaluated 
according to the Nerot classification15 (grade 0 being 
absence of notching and grade 4 being impending 
loosening of the glenoid component). Radiolucent 
lines around the humeral component were classified 
according to their width (≤2 or >2 mm) and zones 
involved (7 zones being described for cemented 
unconstrained stems).16
 Patient satisfaction with the treatment was 
evaluated using a 3-grade scale (satisfied, partially 
satisfied, not satisfied) via a direct interview. Pre- 
and post-operative ROM and Constant scores were 
compared using the paired t test. A p value of <0.01 is 
considered statistically significant.
RESULTS
Three patients were excluded from analysis: one 
died of lung cancer and 2 developed debilitating 
neurological complications unrelated to their surgery. 
The remaining 23 patients were followed up for 26 to 
84 (mean, 42) months. 
 Two complications occurred in the immediate 
postoperative period; one was a partial detachment 
of the lateral deltoid following an anterosuperior 
approach, and the other was a prosthesis dislocation, 
which was promptly reduced and did not recur. Two 
patients had loosening of the glenoid component 
at 6 months and 5 years, for which they underwent 
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revision surgery (Figs. 1 and 2). There were no instances 
of infection, instability, or acromial fracture. No 
complication was related to patient comorbidities. 
 Owing to biomechanical limitation, only active 
elevation improved significantly after surgery.3,10,17 
One patient could not reach the horizontal level and 
underwent conversion to hemiarthroplasty and thus 
was also excluded from analysis. The absolute and 
adjusted Constant scores yielded mean improvements 
of 34 (range, 13–54) and 43% (range, 16%–69%), 
respectively (p<0.0001 in both, Table 1). 12 patients 
were completely pain-free, 9 complained of slight 
pain, and one complained of moderate pain.
Figure 1 Radiographs showing (a) an unstable 
unconstrained shoulder prosthesis associated with pain 
and pseudoparalysis in a rheumatoid patient, (b) a Delta 3 
prosthesis after revision arthroplasty, (c) gross loosening of 
the glenoid component with breakage of 2 screws 6 months 
later, and (d) after replacement of the glenoid component 
using a special metaglene with a plate for additional screw 
fixation (arrow). The bone defect in the scapular neck is filled 
with cancellous bone grafts.
(a) (b)
(c) (d)
Figure 2 Radiographs showing (a) severe glenoid notching 
(Nerot grade 4) with loosening of the glenoid component 5 
years after implantation of the Delta 3 prosthesis, and (b) 
conversion to a hemiarthroplasty owing to the loss of bone 
stock in the scapular neck.
(a) (b)
 The severity of scapular notching progressed 
with time. A notch extending to or beyond the inferior 
screw (Nerot grade 3 or 4) was observed in 5 of the 
10 patients followed up for 5 years (Table 2). Among 
them, 2 were pain-free, one complained of slight pain 
and 2 complained of moderate pain. Their mean 
absolute and adjusted Constant scores were 50 (range, 
43–64) and 62% (range, 50%–81%), respectively.
 Three patients had scapular notching with 
radiolucency of >2 mm in the proximal humerus 
(zones 1 and 7) after 5 years. Four patients had 
heterotopic ossifications in the axillary pouch of the 
glenohumeral joint (Fig. 3). Bone resorption remained 
confined to the metaphyseal area of the humerus and 
did not lead to loosening. 
 15 patients were satisfied with the treatment, 6 
were partially satisfied, and 2 were not satisfied. One 
underwent conversion to hemiarthroplasty and had 
poor functional outcome, the other had impending 
loosening of the glenoid component (a grade-4 notch) 
at 6 years, with worsening of pain and function.
DISCUSSION
The Delta III reverse prosthesis restores mobility 
around a stable centre of rotation and avoids early 
loosening noted with constrained implants.18–20 
Patients treated for cuff tear arthropathy have lower 
complication and revision rates than those treated for 
other disorders.2,17
 The surgical approach may affect postoperative 





p value, t test
Active range of motion
Elevation 65º (53º–78º) 133º (121º–145º) <0.0001
External rotation 16º (10º–22º) 16º (11º–20º) <0.8256
Internal rotation L3 L4 -
Constant score
Adjusted 27% (23%–32%) 70% (64%–75%) <0.0001
Absolute 22 (18–25) 56 (52–60) <0.0001
Subjective variables
Pain 3.6 12.5 <0.0001
Activities of daily living 8.2 15 <0.0001
Objective variables
Range of motion 9.5 25.1 <0.0001
Strength 0.6 3 <0.0001
Table 1
Pre- and post-operative active range of motion and Constant scores in 22 patients*




1 (n=23) 2 (n=23) 3 (n=18) 4 (n=13) 5 (n=10)
1 10 12 8 6 3
2 - 4 6 3 2
3 - - 1 2 3
4 - - 1 1 2
Table 2
Number of patients having different grades of scapular 
notching according to follow-up duration
internal rotation, as the inferior part of the subscapularis 
can be preserved using the anterosuperior but not 
the deltopectoral approach. In our study, the 2 
approaches did not result in significantly different 
ROM. The early contact of the humeral cup with 
the scapular neck limits internal rotation. Fixing the 
humeral component with a retroversion of <20º was 
not sufficient to overcome this problem. In shoulders 
with the reverse prosthesis, external rotation is mainly 
affected by the preoperative integrity of the teres minor 
tendon.21 Therefore, preoperative assessment of the 
teres minor and the degree to which it is affected by 
fatty infiltration should be performed using magnetic 
resonance imaging. In patients without a functional 
teres minor, additional transfer of the latissimus dorsi 
may improve external rotation and elevation.22,23
 The Delta III prosthesis achieves a comparable 
level of pain relief to that of unconstrained implants 
in glenohumeral osteoarthrosis.24–27 It also achieves 
better mobility of the deltoid through medialisation 
of the centre of rotation and lowering of the humerus. 
Nonetheless, none of our patients was able to lift a 
weight of >2.5 kg to the horizontal level; their mean 
Constant score for strength was 3 out of 5. Therefore, 
it can restore active shoulder ROM for the activities of 
daily living, but has low capacity.
 Sufficient bone stock in the scapular neck ensures 
correct positioning and adequate purchase of the 
screws anchoring the metaglene, and thus a stable 
fixation of the glenoid component. In our study, early 
loosening that occurred in the patient with rheumatoid 
arthritis was attributed to insufficient primary fixation 
of the base plate and lack of secondary fixation of 
the hydroxyapatite-coated central peg. Rheumatoid 
shoulders have a higher risk of loosening.9,11
Figure 3 Radiographs showing (a) a Delta III prosthesis for 
an irreparable rotator cuff tear associated with glenohumeral 
osteoarthrosis, and (b) scapular notching (Nerot grade 3), bone 
resorption in the proximal humerus (arrow), and heterotopic 
ossifications (arrowhead) at the 6-year follow-up.
(a) (b)
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